B05. Children and Young Adult Cancer Services

Scope

Membership

Chair: Professor Rachael Hough, Consultant Haematologist at UCLH; Professor of Haematology and Haemopoietic Stem Cell Transplantation UCL
Dr Bernadette Brennan
Prof Darren Hargrave
Dr Helen Hatcher
Dr Julia Chisholm
Dr Michael Ryalls
Dr Rachel Dommett
Dr Dan Stark

Guides to services

NHS England, Teenage Cancer Trust and CLIC Sargent have developed a helpful introduction to services for teenagers and young adults with cancer. It explains the general standards of care to expect from the NHS, and offers some information that may help in making choices about care.

Products

A key part of the CRG’s work is the delivery of the ‘products’ of commissioning. These are the tools used by the 10 Hub Commissioning Teams to contract services on an annual basis.

Service Specifications

Service specifications are important in clearly defining the standards of care expected from organisations funded by NHS England to provide specialised care. The specifications have been developed by specialised clinicians, commissioners, expert patients and public health representatives to describe both core and developmental service standards. Core standards are those that all funded providers should be able to demonstrate, with developmental standards being those which may require further changes in practice over time to provide excellence in the field.

The following service specifications fall within the scope of this CRG:

Policies

A commissioning policy is a document that defines access to a service for a particular group of patients. A NICE Technology Appraisal Guideline on the same topic will replace, or be incorporated into, a commissioning policy as appropriate. These are important documents that are developed to ensure consistency in access to treatments nationwide.

The following policies fall within the scope of this CRG:

Reviewing cancer services for children and young adults

NHS England Specialised Commissioning are currently consulting on revised service specifications for cancer services for Children and Teenagers and Young Adults, and these consultations – open to anyone who wants to respond – will close on 4 August 2019.

Professor Sir Mike Richards has now been asked to assess the consultation responses and advise on the best way forward.

His comprehensive and independent review will include:

  • Meeting with the members of the clinical reference group to hear their views, including of the consultation responses
  • Reviewing available evidence
  • Visits to a number of services across England
  • Hearing directly from patients and families, stakeholders, clinicians, and professional bodies

Professor Richards has undertaken to present his findings and recommendations about the best way forward to the public board meeting of NHS England and NHS Improvement in early 2020.